禁止素1和2的许多“神经面孔”:对健康的大脑至关重要,在许多大脑疾病中失调

IF 2.7 4区 医学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Journal of chemical neuroanatomy Pub Date : 2023-10-01 DOI:10.1016/j.jchemneu.2023.102321
Hans-Gert Bernstein , Karl-Heinz Smalla , Gerburg Keilhoff , Henrik Dobrowolny , Michael R. Kreutz , Johann Steiner
{"title":"禁止素1和2的许多“神经面孔”:对健康的大脑至关重要,在许多大脑疾病中失调","authors":"Hans-Gert Bernstein ,&nbsp;Karl-Heinz Smalla ,&nbsp;Gerburg Keilhoff ,&nbsp;Henrik Dobrowolny ,&nbsp;Michael R. Kreutz ,&nbsp;Johann Steiner","doi":"10.1016/j.jchemneu.2023.102321","DOIUrl":null,"url":null,"abstract":"<div><p><span>Prohibitin<span><span> 1 (PHB1) and prohibitin 2 (PHB2) are proteins that are nearly ubiquitously expressed. They are localized in mitochondria, cytosol and cell nuclei. In the healthy CNS<span><span>, they occur in neurons and non-neuronal cells (oligodendrocytes, astrocytes, microglia, and endothelial cells) and fulfill pivotal functions in brain development and aging, the regulation of </span>brain metabolism, maintenance of structural integrity, </span></span>synapse formation<span>, aminoacidergic neurotransmission<span> and, probably, regulation of brain action of certain hypothalamic-pituitary hormones.With regard to the diseased brain there is increasing evidence that prohibitins are prominently involved in numerous major diseases of the CNS, which are summarized and discussed in the present review (brain tumors, neurotropic viruses, Alzheimer disease<span>, Down syndrome, Fronto-temporal and vascular dementia, </span></span></span></span></span>dementia with Lewy bodies<span><span>, Parkinson disease, </span>Huntington disease<span><span><span>, Multiple sclerosis, </span>Amyotrophic lateral sclerosis, stroke, alcohol use disorder, </span>schizophrenia and autism). Unfortunately, there is no PHB-targeted therapy available for any of these diseases.</span></span></p></div>","PeriodicalId":15324,"journal":{"name":"Journal of chemical neuroanatomy","volume":"132 ","pages":"Article 102321"},"PeriodicalIF":2.7000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The many “Neurofaces” of Prohibitins 1 and 2: Crucial for the healthy brain, dysregulated in numerous brain disorders\",\"authors\":\"Hans-Gert Bernstein ,&nbsp;Karl-Heinz Smalla ,&nbsp;Gerburg Keilhoff ,&nbsp;Henrik Dobrowolny ,&nbsp;Michael R. Kreutz ,&nbsp;Johann Steiner\",\"doi\":\"10.1016/j.jchemneu.2023.102321\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Prohibitin<span><span> 1 (PHB1) and prohibitin 2 (PHB2) are proteins that are nearly ubiquitously expressed. They are localized in mitochondria, cytosol and cell nuclei. In the healthy CNS<span><span>, they occur in neurons and non-neuronal cells (oligodendrocytes, astrocytes, microglia, and endothelial cells) and fulfill pivotal functions in brain development and aging, the regulation of </span>brain metabolism, maintenance of structural integrity, </span></span>synapse formation<span>, aminoacidergic neurotransmission<span> and, probably, regulation of brain action of certain hypothalamic-pituitary hormones.With regard to the diseased brain there is increasing evidence that prohibitins are prominently involved in numerous major diseases of the CNS, which are summarized and discussed in the present review (brain tumors, neurotropic viruses, Alzheimer disease<span>, Down syndrome, Fronto-temporal and vascular dementia, </span></span></span></span></span>dementia with Lewy bodies<span><span>, Parkinson disease, </span>Huntington disease<span><span><span>, Multiple sclerosis, </span>Amyotrophic lateral sclerosis, stroke, alcohol use disorder, </span>schizophrenia and autism). Unfortunately, there is no PHB-targeted therapy available for any of these diseases.</span></span></p></div>\",\"PeriodicalId\":15324,\"journal\":{\"name\":\"Journal of chemical neuroanatomy\",\"volume\":\"132 \",\"pages\":\"Article 102321\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of chemical neuroanatomy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0891061823000911\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of chemical neuroanatomy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0891061823000911","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

禁止蛋白1 (PHB1)和禁止蛋白2 (PHB2)是几乎普遍表达的蛋白。它们定位于线粒体、细胞质和细胞核。在健康的中枢神经系统中,它们存在于神经元和非神经元细胞(少突胶质细胞、星形胶质细胞、小胶质细胞和内皮细胞)中,并在脑发育和衰老、脑代谢调节、结构完整性维持、突触形成、氨基酸能神经传递以及可能调节某些下丘脑-垂体激素的脑活动中发挥关键作用。关于患病的大脑,越来越多的证据表明,禁止药物与许多主要的中枢神经系统疾病(脑肿瘤、嗜神经病毒、阿尔茨海默病、唐氏综合症、额颞叶和血管性痴呆、路易体痴呆、帕金森病、亨廷顿病、多发性硬化症、肌萎缩性侧索硬化症、中风、酒精使用障碍、精神分裂症和自闭症)有显著关系。不幸的是,目前还没有针对这些疾病的phb靶向治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The many “Neurofaces” of Prohibitins 1 and 2: Crucial for the healthy brain, dysregulated in numerous brain disorders

Prohibitin 1 (PHB1) and prohibitin 2 (PHB2) are proteins that are nearly ubiquitously expressed. They are localized in mitochondria, cytosol and cell nuclei. In the healthy CNS, they occur in neurons and non-neuronal cells (oligodendrocytes, astrocytes, microglia, and endothelial cells) and fulfill pivotal functions in brain development and aging, the regulation of brain metabolism, maintenance of structural integrity, synapse formation, aminoacidergic neurotransmission and, probably, regulation of brain action of certain hypothalamic-pituitary hormones.With regard to the diseased brain there is increasing evidence that prohibitins are prominently involved in numerous major diseases of the CNS, which are summarized and discussed in the present review (brain tumors, neurotropic viruses, Alzheimer disease, Down syndrome, Fronto-temporal and vascular dementia, dementia with Lewy bodies, Parkinson disease, Huntington disease, Multiple sclerosis, Amyotrophic lateral sclerosis, stroke, alcohol use disorder, schizophrenia and autism). Unfortunately, there is no PHB-targeted therapy available for any of these diseases.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of chemical neuroanatomy
Journal of chemical neuroanatomy 医学-神经科学
CiteScore
4.50
自引率
3.60%
发文量
87
审稿时长
62 days
期刊介绍: The Journal of Chemical Neuroanatomy publishes scientific reports relating the functional and biochemical aspects of the nervous system with its microanatomical organization. The scope of the journal concentrates on reports which combine microanatomical, biochemical, pharmacological and behavioural approaches. Papers should offer original data correlating the morphology of the nervous system (the brain and spinal cord in particular) with its biochemistry. The Journal of Chemical Neuroanatomy is particularly interested in publishing important studies performed with up-to-date methodology utilizing sensitive chemical microassays, hybridoma technology, immunocytochemistry, in situ hybridization and receptor radioautography, to name a few examples. The Journal of Chemical Neuroanatomy is the natural vehicle for integrated studies utilizing these approaches. The articles will be selected by the editorial board and invited reviewers on the basis of their excellence and potential contribution to this field of neurosciences. Both in vivo and in vitro integrated studies in chemical neuroanatomy are appropriate subjects of interest to the journal. These studies should relate only to vertebrate species with particular emphasis on the mammalian and primate nervous systems.
期刊最新文献
Brain Mechanisms - An evolving perspective on the future of neuroscience. Editorial Board Retraction notice to “Astrocyte response to melatonin treatment in rats under high-carbohydrate high-fat diet” [J. Chem. Neuroanat. 136 (2024) 102389] Retraction notice to “Coenzyme Q10 attenuates neurodegeneration in the cerebellum induced by chronic exposure to tramadol” [J. Chem. Neuroanat. 135 (2024) 102367] Retraction notice to “Maternal diabetes-induced alterations in the expression of brain-derived neurotrophic factor in the developing rat hippocampus” [J. Chem. Neuroanat. 114(2021) 101946]
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1